SHANGHAI (Reuters) - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.


from Reuters: Business News http://ift.tt/1h16ef5
Tidak ada komentar:
Posting Komentar